Drug Clearance on ECMO and Dialysis/CRRT

[1]  D. Ponce,et al.  Different prescribed doses of high-volume peritoneal dialysis and outcome of patients with acute kidney injury. , 2011, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[2]  J. Baird.  The sieving coefficient and clearance of vasopressin during continuous renal replacement therapy in critically ill children. , 2010, Journal of critical care.

[3]  M. Churchwell,et al.  THE CLINICAL APPLICATION OF CRRT—CURRENT STATUS: Drug Dosing During Continuous Renal Replacement Therapy , 2009, Seminars in dialysis.

[4]  Z. Ricci,et al.  Acute kidney injury in an infant after cardiopulmonary bypass. , 2008, Seminars in nephrology.

[5]  P. Peduzzi,et al.  Intensity of renal support in critically ill patients with acute kidney injury. , 2008, The New England journal of medicine.

[6]  M. Baldi,et al.  Successful treatment of a massive atenolol and nifedipine overdose with CVVHDF. , 2008, Minerva anestesiologica.

[7]  J. Fortenberry,et al.  Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[8]  P. Viale,et al.  Pharmacokinetic Considerations for Antimicrobial Therapy in Patients Receiving Renal Replacement Therapy , 2007, Clinical pharmacokinetics.

[9]  S. Vrancken,et al.  Influence of Volume Replacement with Colloids versus Crystalloids in Neonates on Venoarterial Extracorporeal Membrane Oxygenation on Fluid Retention, Fluid Balance, and ECMO Runtime , 2005, ASAIO journal.

[10]  John A Kellum,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[11]  Michael A. Veltri,et al.  Drug Dosing During Intermittent Hemodialysis and Continuous Renal Replacement Therapy , 2004, Paediatric drugs.

[12]  P. Honore,et al.  Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design , 2002, Critical care.

[13]  T. Bunchman,et al.  Dialysis therapy for children with acute renal failure: survey results , 2000, Pediatric Nephrology.

[14]  H. Mulla,et al.  In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation , 2000, Perfusion.

[15]  C. Fraser,et al.  Early initiation of peritoneal dialysis after surgical repair of congenital heart disease , 1999, Pediatric Nephrology.

[16]  C. Fraser,et al.  Peritoneal dialysis. An adjunct to pediatric postcardiotomy fluid management. , 1997, Texas Heart Institute journal.

[17]  R. Bellomo,et al.  Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure , 1994, Critical care medicine.

[18]  L. Schaaf,et al.  Effects of injection site and flow rate on the distribution of injected solutions in an extracorporeal membrane oxygenation circuit. , 1993, American journal of hospital pharmacy.

[19]  G. Koren,et al.  Preliminary Studies of the Effects of Extracorporeal Membrane Oxygenator on the Disposition of Common Pediatric Drugs , 1993, Therapeutic drug monitoring.

[20]  C. A. Schwartz,et al.  Effect of Extracorporeal Membrane Oxygenation on Body Water Content and Distribution in Lambs , 1990, ASAIO Transactions.

[21]  R H Bartlett,et al.  Extracorporeal life support for cardiopulmonary failure. , 1990, Current problems in surgery.

[22]  D. Rosen,et al.  A474 UPTAKE OF LORAZEPAM AND MIDAZOLAM BY THE SCIMED MEMBRANE OXYGENATOR , 1990 .

[23]  K. Omote,et al.  Serotonergic mediation of spinal analgesia and its interaction with noradrenergic systems. , 1988, Anesthesiology.

[24]  P. Neuvonen,et al.  Thiopentone pharmacokinetics during cardiopulmonary bypass with a nonpulsatile or pulsatile flow , 1989, Acta anaesthesiologica Scandinavica.

[25]  W. Debois,et al.  Pro: pulsatile flow is preferable to nonpulsatile flow during cardiopulmonary bypass. , 1987, Journal of cardiothoracic anesthesia.

[26]  R. Cork,et al.  Fentanyl sequestration in lungs during cardiopulmonary bypass , 1983, Clinical pharmacology and therapeutics.

[27]  C. Mavroudis,et al.  To pulse or not to pulse. , 1978, The Annals of thoracic surgery.